Ou Huang
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 53
- Cancer Genomics and Diagnostics 8
- Oncology 64
- HER2/EGFR in Cancer Research 34
- Cancer Treatment and Pharmacology 13
- Cancer Risks and Factors 8
Ou Huang
93 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 101
- Cancer Research 818
- Oncology 892
- Pathology and Forensic Medicine 343
- Immunology 217
- Molecular Medicine 40
Countries citing papers authored by Ou Huang
This map shows the geographic impact of Ou Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ou Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ou Huang more than expected).
Fields of papers citing papers by Ou Huang
This network shows the impact of papers produced by Ou Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ou Huang. The network helps show where Ou Huang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ou Huang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 13 | |
| 4 | 2023 | 0 | |
| 5 | 2022 | 6 | |
| 6 | 2021 | 18 | |
| 7 | 2021 | 1 | |
| 8 | 2021 | 3 | |
| 9 | 2020 | 7 | |
| 10 | 2020 | 14 | |
| 11 | 2019 | 14 | |
| 12 | 2017 | 0 | |
| 13 | 2017 | 7 | |
| 14 | [Risk factors of non-sentinel lymph node metastasis and performance of MSKCC nomogramin breast cancer patients with metastatic sentinel lymph node]. | 2015 | 6 |
| 15 | 2015 | 26 | |
| 16 | 2015 | 42 | |
| 17 | 2014 | 21 | |
| 18 | 2013 | 50 | |
| 19 | 2011 | 23 | |
| 20 | 2007 | 99 |
About Ou Huang
Ou Huang is a scholar working on Cancer Research, Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Obstetrics and Gynecology, having authored 100 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (53 papers), HER2/EGFR in Cancer Research (34 papers), Breast Lesions and Carcinomas (19 papers), Advanced Breast Cancer Therapies (13 papers), Cancer Treatment and Pharmacology (13 papers), Cancer Risks and Factors (8 papers), Cancer Genomics and Diagnostics (8 papers) and Metabolism, Diabetes, and Cancer (6 papers). The work is most often cited by research in Cancer Research (818 citations), Oncology (892 citations), Pathology and Forensic Medicine (343 citations), Immunology (217 citations) and Molecular Medicine (40 citations). Ou Huang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Kunwei Shen, Xiaosong Chen, Jiayi Wu, Yan Mao, Weiguo Chen, Yafen Li, Jianrong He, Xiaochun Fei, Li Zhu and Qing Qu. Their work appears in journals such as BMC Cancer, Frontiers in Oncology, PLoS ONE, Oncotarget and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.